Connecticut's Premiere Stem Cell Conference will be held virtually over two half days - April 1 & April 8. Join us! Connecticut’s premier conference on...

Small companies are laser-focused on understanding biology and identifying a target therapeutic – but what happens once you have a lead compound? How can you...

The first webinar of the series will outline how the blending of discovery and development teams and profiling activities, often considered only in development, within...

On March 11, 2021, President Biden signed the American Rescue Plan Act of 2021 (ARPA) into law, which includes important updates to certain benefits laws in response to the...

Championing Early-Stage Bio-Entrepreneurs Boehringer Ingelheim knows what it takes to be innovative and entrepreneurial. From the small factory in 1885 to today’s multi-billion-dollar global organization,...

Join Insperity’s Megan Manion, Director of Customer Service Operations and Cindy DeMarco, Manager of Insperity’s Strategic Consulting Services team for this highly relevant and informative session....

Panel discussion: Why is it so important to connect with other women in bio? Opening remarks - Susan Sobolov, Connecticut Chapter Chair and Lisa Iannucci, Executive...

Designing and selecting appropriate lead candidates is key in reducing clinical attrition and costs associated with the development of new drugs. To ensure a smooth...

DNA-encoded library (DEL) technology has the potential to revolutionize drug discovery. In the last decade, the technology has become a mainstay within the industry for its...

Did you know… The U.S. Department of Health and Human Services is one of the largest sources of early-stage capital for life sciences in the U.S.?...